NCT01824537View on ClinicalTrials.gov

Transmission Reduction and Prevention With HPV Vaccination (TRAP-HPV) Study

PHASE4CompletedINTERVENTIONAL
Enrollment

372

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

November 18, 2022

Study Completion Date

November 18, 2022

Conditions
Human Papillomavirus Infection
Interventions
BIOLOGICAL

HPV vaccine, Gardasil 9

Once recruited, both individuals in a couple will be randomized independently to Gardasil 9 or placebo (Avaxim).

BIOLOGICAL

Hepatitis A vaccine

Provided by Sanofi Pasteur.

Trial Locations (1)

H4A 3T2

McGill University - Division of Cancer Epidemiology, Montreal

All Listed Sponsors
lead

McGill University

OTHER

NCT01824537 - Transmission Reduction and Prevention With HPV Vaccination (TRAP-HPV) Study | Biotech Hunter | Biotech Hunter